KLTO Klotho Neurosciences
- 0.388
- +0.048+14.12%
- 0.373
- -0.015-3.87%
Klotho Neurosciences News
10-Q: Quarterly report
Klotho Neurosciences Ends Licensing Agreement With Teleost
Express News | Klotho Neurosciences - Co, Teleost Biopharmaceuticals LLC Mutually Agreed to Terminate Licensing Agreement Dated Jan 28, 2023
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Klotho Neurosciences Names Peter Moriarty as COO
Express News | Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences
12 Health Care Stocks Moving In Wednesday's Intraday Session
Express News | DR. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (Klto)
Express News | Anew Medical, Inc. Announces Name Change to Klotho Neurosciences, Inc.
ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Express News | Anew Medical Inc Files Prospectus for Offering & Resale by Selling Stockholders of up to 21.5 Mln Shares of Common Stock - SEC Filing
Healthy Longevity Is One of Key Development Goals of ANEW's Novel Gene Therapy
Shares of Companies Within the Broader Financial Sector Are Trading Lower Amid Overall Market Sentiment as Investors Evaluate NVIDIA Ahead of Its Earnings Report and SMCI Form 10-K Delay.
Anew Medical Reduces Debt by $4 Million
ANEW MEDICAL, INC. Achieves Debt-Free Status, Boosts Financial Flexibility
Anew Medical Gets Two Noncompliance Letters From Nasdaq
ANEW Medical Welcomes New CFO and COO With Equity Awards
What's Going On With Anew Medical Stock?
Analysis
Price Target
No Data
No Data